DE2935902A1
Expired / Lapsed
DE
⏱️ 0.0 years remaining
Omega-oxazolinyl alkanoic acid derivs. - useful as thrombocyte aggregation inhibitors, e.g. for treating thrombosis, arteriosclerosis and inflammation
Assignee: A Natterman und Cie GmbH
•
Filing: 1979-09-05
•
Granted: —
•
Expires: 1999-09-05
Abstract
Abstract Oxazoline derivs. of formula (I), their salts and esters, are new (where n is 1-11; R1 and R2 are H, thienyl or opt. substd. phenyl; R3 is H, alkali ion, opt. branched 1-6C hydrocarbyl or aralkyl). They are prepd. e.g. by reacting an N-H analogue with an alkali and then with a haloalkanoate. (I) are thrombocyte aggregation inhibitors so are useful for treating or preventing thrombosis, arteriosclerosis and inflammations, opt. in conjunction with an anticoagulant (esp. heparin, a heparin salt and coumarin deriv.). They are well tolerated by the stomach and have oral LD50 (mouse) at least 2g per kg.
Inventors
- 👤 Dipl.-Chem. Dr. Hans 5014 Kerpen Betzing
- 👤 Dipl.-Chem. Dr. Hans-Heiner 5000 Köln Lautenschläger
- 👤 Dipl.-Chem. Dr. Manfred 5020 Frechen Probst
- 👤 Brigitte 5000 Köln Stoll
Bibliographic Details
Application Number
—
Jurisdiction
DE
Data Source
google_patents
Last Synchronized
2026-11-05 10:49
CPC Classifications
C; C07; C07D; C07D263/00; C07D263/02; C07D263/30; C07D263/34; C07D263/36; C07D263/38
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.